Alzheimer s Disease Pilot Clinical Trials (R01)
The summary for the Alzheimer s Disease Pilot Clinical Trials (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Alzheimer s Disease Pilot Clinical Trials (R01): n 1999, at the direction of Congress, the National Institute on Aging (NIA), in conjunction with the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Mental Health (NIMH), and the National Institute of Nursing Research (NINR) embarked on the Alzheimer's Disease (AD) Prevention Initiative, which encompasses a number of interrelated efforts including basic, epidemiological, behavioral, and clinical research. An important part of the AD Prevention Initiative is to quicken the pace for translating basic science findings into clinical trials to evaluate treatment and prevention strategies. This funding opportunity announcement (FOA) focuses on AD pilot clinical trials while another FOA is targeted to AD drug discovery. In this FOA the NIA invites qualified investigators to submit research grant applications for pilot clinical drug trials directed toward the prevention and treatment of the cognitive and behavioral symptoms of mild cognitive impairment (MCI), Alzheimer's disease (AD), and age-related cognitive decline. This Funding Opportunity Announcement (FOA) issued by the National Institute on Aging (NIA), National Institutes of Health, solicits Research Project Grant (R01) applications from institutions/ organizations that propose to initiate pilot clinical trials for treatment or prevention of MCI, AD, and/or age related cognitive decline. Purpose. The objective of the Alzheimer s Disease Pilot Clinical Trials initiative is to improve the quality of clinical research designed to evaluate interventions for the prevention or treatment of Alzheimer s disease (AD), mild cognitive impairment (MCI), and age-associated cognitive decline by stimulating applications for pilot clinical drug trials to test interventions aimed at delaying the onset of or preventing AD, MCI, and age-associated cognitive decline; slowing, halting, or, if possible, reversing the progressive decline in cognitive function; and modifying the cognitive and behavioral symptoms in Alzheimer s disease. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. It is expected that most grants will not exceed $400,000 per year in direct costs (exclusive of indirect costs for subcontracts to additional clinical sites) for up to 3 years. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received.
|Federal Grant Title:||Alzheimer s Disease Pilot Clinical Trials (R01)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PAR-07-142|
|Type of Funding:||Grant|
|CFDA Descriptions:||Aging Research|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Dec 12, 2006|
|Creation Date:||Dec 13, 2006|
|Archive Date:||Dec 06, 2007|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Private institutions of higher education County governments Public and State controlled institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Independent school districts For profit organizations other than small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Similar Government Grants
- • MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavior...
- • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Requ...
- • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinica...
- • Transition to Aging Research for Predoctoral Students (F99/K00)
- • Integrative Research to Understand the Impact of Sex Differences on the Molecular Determin...
- • Technological Enhancements and Archiving for Surveys of the Elderly: SBIR (R43/44) Initiat...
- • Technological Enhancements and Archiving for Surveys of the Elderly: STTR (R41/42) Initiat...
- • Technology and Aging: NIA Small Business Technology Transfer Program Initiative (STTR [R41...
- More Grants from the National Institutes of Health
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
- • New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...